Your DNA is a valuable asset, so why give it to ancestry websites for free?
The Guardian -

DNA testing companies are starting to profit from selling our data on to big pharma. Perhaps they should be paying us

The announcement by 23andMe, a company that sells home DNA testing kits, that it has sold the rights to a promising new anti-inflammatory drug to a Spanish pharmaceutical company is cause for celebration. The collected health data of 23andMe’s millions of customers have potentially produced a medical advance – the first of its kind. But a few weeks later the same company...

Read this story at


Related Articles